---
layout: post
title: "天宇股份：原料药利伐沙班获得CEP证书"
date: 2022-01-27 16:39:24 +0800
categories: emnews
tags: 东财滚动新闻
---
> 天宇股份公告，公司原料药利伐沙班获得CEP证书。利伐沙班属于抗凝血药物，用于髋关节或膝关节置换手术成年患者。（财联社）

<p><span id="stock_0.300702"><a href="http://quote.eastmoney.com/unify/r/0.300702" class="keytip" data-code="0,300702">天宇股份</a></span><span id="quote_0.300702"></span><span id="Info.3332"><a href="http://data.eastmoney.com/notices/" class="infokey">公告</a></span>，公司原料药利伐沙班获得CEP证书。利伐沙班属于抗凝血药物，用于髋关节或膝关节置换手术成年患者。</p><p class="em_media">（文章来源：财联社）</p>

<http://finance.eastmoney.com/news/1354,202201272264292551.html>

[返回东财滚动新闻](//finews.withounder.com/emnews/)｜[返回首页](//finews.withounder.com/)